Considering breast cancer, molecular, and cellular mechanisms of HDAC and mTOR inhibition, and the abovementioned proved enzyme-inhibitor-breast cancer correlations, the overarching goal of this study is the development of effective anticancer agents to combat with one of the major health problems in the world, i.e., breast cancer brain metastasis. Here, HDAC9 is linked to breast carcinoma.